Drawing for EVALAR

USPTO serial 79164979

EVALAR

Reviewed by CopyMark Law Group

Reg. 4961976Status 708Renewal
Filing date
Status date
Registration date
May 24, 2016
Examiner
JOINER, KATINA JACKSON
Law office
—

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with EVALAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elise Tenen-Aoki

Elise Tenen-Aoki TA IP Law, P.C. A Law Corporation14271 Jeffrey Road, Suite 313Irvine, CA 92620UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003[ Greases for cosmetic purposes; cosmetic creams; hair lotions; lotions for cosmetic purposes; beauty masks; oils for cosmetic purposes; essential oils; cleansing milk for toilet purposes; cosmetic preparations for baths; non-medicated mouthwash; cosmetic preparations for slimming purposes; sunscreen preparations; potpourri; cosmetic sun-tanning preparations; cosmetic preparations for skin care; cosmetics; shampoos; extracts of flowers sold as components of cosmetics; ethereal essences and extracts of herbs for cosmetic purposes ]SECTION 71 - CANCELLED—
005[ Analgesics; antibiotics; balms for medical purposes; dietary fiber for use as an ingredient in the manufacture of dietary supplements; ] mineral food supplements; nutritional supplements; [ medicinal roots; collodion for pharmaceutical purposes; licorice for pharmaceutical purposes; candy for medical purposes; medicines for alleviating constipation; liniments; antibiotic ointments; medicinal oils for the treatment of skin diseases, for use as medicated skin care preparations, as medicated hair care preparations; drugs for medical purposes, namely, antimicrobial preparations for inhibiting microbiological decomposition in food, beverages and pharmaceuticals; medicines for human purposes, namely, pharmaceutical preparations for treating of disorders of gastrointestinal system; medicinal drinks; flour for pharmaceutical purposes; mint for pharmaceutical purposes; medicinal infusions for treating of disorders of the nervous, immune, cardiovascular and metabolic systems, the gastro-intestinal system, the respiratory and genito-urinary systems, musculo-skeletal and inflammatory disorders, for use in dermatology, ophthalmology; decoctions for pharmaceutical purposes for treating of disorders of the nervous, immune, cardio-vascular and metabolic systems, the gastro-intestinal system, the respiratory and genito-urinary systems, musculo-skeletal and inflammatory disorders, for use in dermatology, ophthalmology; food for babies; ] vitamin preparations; [ hemorrhoid treatment preparations; eye-washes; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for skin care; medicinal hair growth preparations; ] preparations of trace elements for human use for the prevention and treatment of disorders of the nervous system, the immune system, the cardlo-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genito-urinary system, the gastro-intestinal system, for use as dietetic supplements, nutritional additives for medical purposes; [ pharmaceutical preparations for the treatment of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the rnusculo-skeletal system, the genito-urinary system, the gastro-intestinal system, for the treatment of inflammatory disorders, for use in dermatology; enzyme preparations for medical purposes for the treatment of disorders of gastro-intestinal system; chemico-pharmaceutical preparations for the treatment of disorders of the nervous system, the immune system, the vascular and metabolic systems, the respiratory and genito-urinary systems, musculoskeletal and inflammatory disorders or for use in dermatology, ophthalmology, for gastro-enterology, for the prevention and treatment of ocular disorders, for use as anti-infective, antiparasitic, antibiotic, anti-bacterial, antiviral and antifungal; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of disorders of the nervous system, the immune system, the vascular and metabolic systems, the respiratory and genito-urinary systems, musculoskeletal and inflammatory disorders or for use in dermatology, ophthalmology, for gastro-enterology, for the prevention and treatment of ocular disorders, for use as anti-infective, antiparasitic, antibiotic, anti-bacterial, antiviral and antifungal; collyrium; dietetic foods, namely, crackers adapted for medical use; by-products of the processing of cereals for medical purposes; propolis for medicinal or therapeutic purposes; asthmatic tea; ] linseed dietary supplements [ ; syrups for pharmaceutical purposes for the treatment of cough; soporifics; bath salts for medical purposes; malt for pharmaceutical purposes; medicinal alcohol; appetite suppressants for medical purposes; medical preparations for slimming purposes; mouthwashes for medical purposes; febrifuges; purgatives; antiparasitic preparations; sedatives; tranquilizers; laxatives; digestives for pharmaceutical purposes; appetite suppressant pills; slimming pills; medicinal herbs; charcoal for pharmaceutical purposes; enzymes for medical purposes; medicinal tea; herbal teas for medicinal purposes; plant and herb extracts for medicinal purposes; elixirs, namely, pharmaceutical preparations for the treating of disorders of the nervous, immune, cardio-vascular and metabolic systems, the gastro-intestinal system, the respiratory and genito-urinary systems, musculo-skeletal and inflammatory disorders, for use in dermatology ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 24, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Dec 19, 2024RNWLINTERNATIONAL REGISTRATION RENEWED—
Jan 31, 2023INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Dec 7, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Dec 7, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
Nov 11, 2022INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 11, 2022NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Mar 11, 2022C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Mar 9, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 12, 2021ES75TEAS SECTION 71 & 15 RECEIVED—
Jun 14, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 14, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 14, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 14, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 14, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 14, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 21, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 25, 2016XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Aug 25, 2016XXCRGENERIC MADRID TRANSACTION CREATED—
Aug 24, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 24, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 8, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2016GPNXNOTIFICATION PROCESSED BY IB—
Feb 17, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 17, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 17, 2016NPUBNOTICE OF PUBLICATION—
Feb 2, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 1, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 30, 2016ACECAMENDMENT FROM APPLICANT ENTERED—
Jan 30, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 27, 2016MAILPAPER RECEIVED—
Dec 3, 2015CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2015ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Nov 10, 2015PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Oct 28, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 26, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 5, 2015ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 5, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 25, 2015ALIEASSIGNED TO LIE—
Sep 10, 2015MAILPAPER RECEIVED—
Jun 7, 2015RFNTREFUSAL PROCESSED BY IB—
May 21, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 21, 2015RFRRREFUSAL PROCESSED BY MPU—
May 21, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 20, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 19, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
May 16, 2015DOCKASSIGNED TO EXAMINER—
May 15, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 15, 2015LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
May 14, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance